Meeting this expectation, CD163 surface expression was lower on Mo1 and Mo2 monocytes from HD patients compared to healthy subjects, although there is a large variability within both cohorts (Table 1, Fig. 1E; Mo1: CON/HD pre: p = 0.3, CON/HD post: p = 0.3; Mo2: CON/HD pre: p = 0.03, CON/HD post: p = 0.004, HD pre/post: p = 0.002). The gene discussed is CD163; the disease is Huntington disease.